Should <i>JAK2</i> V617F Mutation Testing be Inducted into Routine Thrombophilia Screening? [PDF]
Langabeer SE.
europepmc +1 more source
JAK2 V617F Mutation Leading to Portal Vein Thrombosis in a Young Patient: A Case Report. [PDF]
Patil C +4 more
europepmc +1 more source
Analysis of the reannealing- instead of melting-curve in the detection of JAK2 V617F mutation by HRM method. [PDF]
Moradabadi A +2 more
europepmc +1 more source
Cerebral venous sinus thrombosis associated with JAK2 V617F mutation-related pre-primary myelofibrosis: a case report and literature review. [PDF]
Song J +8 more
europepmc +1 more source
Detection of the JAK2 V617F Mutation in Urinary Cell-free DNA in Patients with Myeloproliferative Neoplasms. [PDF]
Hosoi H +9 more
europepmc +1 more source
Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation. [PDF]
Rao R, Grosel J.
europepmc +1 more source
CRISPR/Cas9-Based Modeling of <i>JAK2</i> V617F Mutation in K562 Cells Reveals Enhanced Proliferation and Sensitivity to Therapeutic Agents. [PDF]
Nilsri N +4 more
europepmc +1 more source
Laboratory-developed Droplet Digital PCR Assay for Quantification of the JAK2 <sup>V617F</sup> Mutation. [PDF]
Liu Y +7 more
europepmc +1 more source
JAK2-tree: a simple CBC-based decision rule to guide appropriate JAK2 V617F mutation testing. [PDF]
Mahe E +7 more
europepmc +1 more source
Molecular Abnormalities and Associated Clinical Features in Polycythemia Vera. [PDF]
Testa U, Castelli G, Pelosi E.
europepmc +1 more source

